Cargando…

Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals

BACKGROUND: Serology testing is explored for epidemiological research and to inform individuals after suspected infection. During the coronavirus disease 2019 (COVID-19) pandemic, frontline healthcare professionals (HCP) may be at particular risk for infection. No longitudinal data on functional ser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behrens, Georg M. N., Cossmann, Anne, Stankov, Metodi V., Schulte, Bianca, Streeck, Hendrik, Förster, Reinhold, Bosnjak, Berislav, Willenzon, Stefanie, Boeck, Anna-Lena, Thu Tran, Anh, Thiele, Thea, Graalmann, Theresa, Kayser, Moritz Z., Zychlinsky Scharff, Anna, Dopfer, Christian, Horke, Alexander, Pink, Isabell, Witte, Torsten, Wetzke, Martin, Ernst, Diana, Jablonka, Alexandra, Happle, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472691/ https://www.ncbi.nlm.nih.gov/pubmed/32886335 http://dx.doi.org/10.1007/s40121-020-00334-1

Ejemplares similares

Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals
por: Behrens, Georg M. N., et al.
Publicado: (2020)

SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study
por: Dopfer-Jablonka, Alexandra, et al.
Publicado: (2022)

COVID-19 related reduction in pediatric emergency healthcare utilization – a concerning trend
por: Dopfer, Christian, et al.
Publicado: (2020)

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
por: Barros-Martins, Joana, et al.
Publicado: (2021)

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
por: Nehlmeier, Inga, et al.
Publicado: (2023)

Disease burden in a large cohort of asylum seekers and refugees in Germany
por: Müller, Frank, et al.
Publicado: (2021)

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2021)

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
por: Behrens, Georg M. N., et al.
Publicado: (2022)

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern
por: Odak, Ivan, et al.
Publicado: (2022)

Health workers’ perception vs medically approved COVID-19 infection risk: the risk communication gap: Ellen Kuhlmann
por: Kuhlmann, E, et al.
Publicado: (2022)

Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2022)

Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
por: Jedicke, Nils, et al.
Publicado: (2021)

Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study
por: Jablonka, Alexandra, et al.
Publicado: (2017)

Healthcare Workers' Perceptions and Medically Approved COVID-19 Infection Risk: Understanding the Mental Health Dimension of the Pandemic. A German Hospital Case Study
por: Kuhlmann, Ellen, et al.
Publicado: (2022)

Healthcare Utilization in a Large Cohort of Asylum Seekers Entering Western Europe in 2015
por: Wetzke, Martin, et al.
Publicado: (2018)

SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
por: Behrens, Georg MN, et al.
Publicado: (2021)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

Hide and seek with SARS-CoV-2: spike receptor-binding domain-specific memory B cells still recognize Omicron variant
por: Odak, Ivan, et al.
Publicado: (2022)

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals
por: Barros-Martins, Joana, et al.
Publicado: (2023)

The risk management of contingent convertible (CoCo) bonds
por: De Spiegeleer, Jan, et al.
Publicado: (2018)

Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination
por: Dulovic, Alex, et al.
Publicado: (2022)

Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
por: Arora, Prerna, et al.
Publicado: (2023)

Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
por: Bošnjak, Berislav, et al.
Publicado: (2020)

Pregnancy Related Health Care Needs in Refugees—A Current Three Center Experience in Europe
por: Dopfer, Christian, et al.
Publicado: (2018)

Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
por: Gussarow, Daniel, et al.
Publicado: (2021)

The Handbook of Hybrid Securities: Convertible Bonds, CoCo Bonds and Bail-In
por: Van Hulle, Cynthia
Publicado: (2014)

Acute respiratory infections in an adult refugee population: an observational study
por: Jablonka, Alexandra, et al.
Publicado: (2021)

Tuberculosis Specific Interferon-Gamma Production in a Current Refugee Cohort in Western Europe
por: Jablonka, Alexandra, et al.
Publicado: (2018)

Pediatric Healthcare Utilization in a Large Cohort of Refugee Children Entering Western Europe During the Migrant Crisis
por: Happle, Christine, et al.
Publicado: (2019)

Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy
por: Bošnjak, Berislav, et al.
Publicado: (2021)

The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice
por: Do, Kim Thi Hoang, et al.
Publicado: (2023)

Protocol of the Cologne Corona Surveillance (CoCoS) Study– a prospective population-based cohort study
por: Oberste, Max, et al.
Publicado: (2021)

CoCo: RNA-seq read assignment correction for nested genes and multimapped reads
por: Deschamps-Francoeur, Gabrielle, et al.
Publicado: (2019)

The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
por: Arora, Prerna, et al.
Publicado: (2022)

Versorgung von rheumatologischen Patienten während des Lockdowns im Frühjahr 2020: Telemedizin, Delegation, Patientenzufriedenheit und Impfverhalten
por: Thiele, Thea, et al.
Publicado: (2021)

CoCo trial: Color-coded blood pressure Control, a randomized controlled study
por: Chmiel, Corinne, et al.
Publicado: (2014)

The Comorbidities Coma Scale (CoCoS): Psychometric Properties and Clinical Usefulness in Patients With Disorders of Consciousness
por: Pistoia, Francesca, et al.
Publicado: (2019)

SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
por: Arora, Prerna, et al.
Publicado: (2022)

Changes in Alcohol Consumption, Eating Behaviors, and Body Weight during Quarantine Measures: Analysis of the CoCo-Fakt Study
por: Wessely, Stefanie, et al.
Publicado: (2022)

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
por: Arora, Prerna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9t8fifvk0h1fpk9j5ukhekne3e